Michael Major

26PUBLICATIONS

216CO-AUTHORS

Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|May 21, 2026

A MAFG~MITF complex drives melanoma phenotype switching and progression.

|Mar 20, 2026

Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.

Tito A Sandoval, Yize Li, Naoshad Muhammad

|Dec 19, 2025

A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth.

Nilotpal Roy, Tine Wyseure, I-Chung Lo

|Oct 11, 2025

Activating NRF2<sup>E79Q</sup> mutation alters the differentiation of human non-small cell lung cancer.

Samera H Hamad, Hansa Joshi, T Hess

|Sep 15, 2025

Mapping of the hSOX10 protein interactome in human melanoma.

Catherine M Newsom-Stewart, Dhaval P Bhatt, Michael B Major

|Sep 13, 2025

NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting.

Harit Panda, Natalie G Rowland, Caroline M Krall

Pageof 5

Frequent Collaborators

Brittany M Bowman

Ilah Bok

Tigist Y Tamir

D Neil Hayes

Jeremy Simon

Paul Zolkind

Dhaval P Bhatt

Kyle M LaPak

Xiaoxin L Chen

Bernard E Weissman

Frequent Collaborators

Brittany M Bowman

Ilah Bok

Tigist Y Tamir

D Neil Hayes